The Food and Drug Administration (FDA) is seeking to disqualify Daniel Berger, MD, a prominent Chicago HIV doctor, from future drug studies after finding that his clinic submitted fictitious data in a trial of a drug that treats chronic diarrhea in people with HIV, the Chicago Breaking News Center reports. After finding that doctors' and patients' signatures were forged, basic tests were not performed and more than 200 tablets of the investigational drug were missing, the FDA concluded that Berger “failed to protect the rights, safety and welfare of patients.”

To read the Chicago Breaking News Center article, click here.